Evidence map›Paper›PMID 34068772›Full record

ArticleMembranes2021

Effect of F16-Betulin Conjugate on Mitochondrial Membranes and Its Role in Cell Death Initiation.

Mikhail V Dubinin, Alena A Semenova, Darya A Nedopekina, Eldar V Davletshin, Anna Yu Spivak, Konstantin N Belosludtsev

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Effects ofInternational journal of molecular sciences · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Targeting Energy Metabolism in Cancer Treatment.International journal of molecular sciences · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mikhail V DubininDepartment of Biochemistry, Cell Biology and Microbiology, Mari State University, pl. Lenina 1, 424001 Yoshkar-Ola, Russia.ORCID 0000-0002-7453-3390
Alena A SemenovaDepartment of Biochemistry, Cell Biology and Microbiology, Mari State University, pl. Lenina 1, 424001 Yoshkar-Ola, Russia.
Darya A NedopekinaInstitute of Petrochemistry and Catalysis, Russian Academy of Sciences, Prospekt Oktyabrya 141, 450075 Ufa, Russia.ORCID 0000-0002-3845-9541
Eldar V DavletshinInstitute of Petrochemistry and Catalysis, Russian Academy of Sciences, Prospekt Oktyabrya 141, 450075 Ufa, Russia.
Anna Yu SpivakInstitute of Petrochemistry and Catalysis, Russian Academy of Sciences, Prospekt Oktyabrya 141, 450075 Ufa, Russia.ORCID 0000-0001-8752-2853
Konstantin N BelosludtsevDepartment of Biochemistry, Cell Biology and Microbiology, Mari State University, pl. Lenina 1, 424001 Yoshkar-Ola, Russia.ORCID 0000-0001-5392-7035
Institute of Catalysis and Petrochemistry · RUMari State University · RU

Funding

Russian Foundation for Basic Research 20-015-00124Russian Science Foundation 19-73-00155
6 · The paper itself

Abstract

This work demonstrates the effects of a newly synthesized conjugate of the plant triterpenoid betulin and the penetrating cation F16 used for mitochondrial targeting. The resulting F16-betulin conjugate revealed a mitochondria-targeted effect, decreasing the mitochondrial potential and inducing superoxide overproduction in rat thymocytes

Indexed as

betulinF16mitochondriaoxidative phosphorylationROSthymocytes

Identifiers

PMID34068772
PMCPMC8151401
OpenAlexW3161804418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.